Skip to content

AgomAb Therapeutics

Active
Public limited companyfounded 2017active for 9 yearsPosthoflei 1, 2600 Antwerpen, Belgium10 active companies are registered at this addressKBO/BCE: BE 0674.527.310
Summary

AgomAb Therapeutics has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €244.1m and a net result of -€9.6m. Equity is growing by about 109% per year across the filed financial years. Its solvency ranks better than 95% of 886 sector peers (NACE 71, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
AgomAb TherapeuticsActiveChecked score 95/100
Risk analysis ReportCompare

History

AgomAb Therapeutics was incorporated on 13 April 2017 by EUREMAB SRL, DE HAARD ANTIBODY TECHNOLOGIES B.V. and five natural persons, with a starting capital of €25,000.12 Since 2017 the registered office has moved 4 times, most recently to Berchem in 2024.34 Between 2018 and 2026 the capital was increased 16 times, most recently to €303.3m.567 The board currently has 9 members; 2 of them have served since 2019.8 Total assets rose from €333,024 in 2018 to €251.3m in 2025 and headcount from 1 full-time equivalents in 2019 to 52 in 2025.9

  1. 1KBO register
  2. 2Belgian Official Gazette, 18-04-2017
  3. 3Belgian Official Gazette, 30-08-2017
  4. 4Belgian Official Gazette, 09-04-2024
  5. 5Belgian Official Gazette, 14-03-2018
  6. 6Belgian Official Gazette, 17-04-2026
  7. 7Belgian Official Gazette, 26-10-2026
  8. 8Belgian Official Gazette, 17-06-2025
  9. 9National Bank, annual accounts 2018, 2019 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
26-10
Gazette deed Capital & shares
Power of attorney · Capital increase · Share issue6 facts ▸
  • Power of attorney
  • Capital increase, €229,347.31
  • Share issue, “gewone aandelen”, 210170 (deed in Dutch)
  • Share transfer, AgomAb Therapeutics
  • Amendment of the articles, 5
  • Capital, €303,287,161.22
12-10
Gazette deed Appointments: Marino Garcia (non-executive director) and Naimish Patel (non-executive director)
Financial instrument5 facts ▸
  • General meeting, 11-09-2026
  • Director appointment, Marino Garcia (non-executive director)
  • Director appointment, Naimish Patel (non-executive director)
  • Financial instrument, “consolidatie en splitsing, niet van toepassing op de Post-IPO Inschrijvingsrechten” (deed in Dutch)
  • Other provision, “praktisch voorbeeld Inschrijvingsrechtensplitsing”, EUR (deed in Dutch)
23-06
NBB filing Annual accounts filed
financial year 2025 · full format
19-06
Gazette deed Reappointments: Ohad Hammer (director) and Tim Knotnerus (director)
3 facts ▸
  • General meeting, 26-05-2026
  • Director reappointment, Ohad Hammer (director)
  • Director reappointment, Tim Knotnerus (director)
17-04
Gazette deed Capital & shares · Amendment of the articles
Financial instrument · Capital increase · Share issue9 facts ▸
  • Financial instrument, 26, “exercise request” (deed in Dutch)
  • Capital increase, €64,467.19
  • Share issue, “gewone aandelen”, 28229 (deed in Dutch)
  • Amendment of the articles, 5
  • Capital, €303,057,813.91
  • Financial instrument, 562, “exercise request” (deed in Dutch)
  • Financial instrument, 440, “exercise request” (deed in Dutch)
  • Financial instrument, 276, “exercise request” (deed in Dutch)
  • Other provision, “special proxy holder appearance, AgomAb Therapeutics” (deed in Dutch)
08-04
Gazette deed Capital & shares · Amendment of the articles
Power of attorney · Capital increase · Capital13 facts ▸
  • Board meeting, 28-01-2026
  • Board meeting, 05-02-2026
  • Power of attorney, Tim Knotnerus (2 times)
  • Other provision, 05-02-2026 (2 times)
  • Capital increase
  • Capital, €302,993,346.72
  • Capital increase, €2,973,096.56
  • Share issue, “gewone aandelen”, 482967 (deed in Dutch)
  • Amendment of the articles, 5
  • Other provision, “bestuurder”, 04-03-2026 (deed in Dutch)
  • Capital, €300,020,250.16
  • Other provision, “schriftelijke kennisgeving van de Underwriters over uitoefening Overtoewijzingsoptie, USD” (deed in Dutch)
  • +1 further fact in this act
11-03
Gazette deed Resignation: Xiaoming Fang (klasse b investeerder bestuurder)
7 facts ▸
  • Director resignation, Xiaoming Fang (klasse b investeerder bestuurder)
  • Board composition, Angelika Martha Jahreis (independent director)
  • Board composition, Colin Bond (independent director)
  • Board composition, David Epstein (voorzitter bestuurder en onafhankelijk bestuurder)
  • Board composition, Felice Isabel Verduyn - Van Weegen (klasse c investeerder bestuurder)
  • Board composition, Ohad Hammer (klasse a investeerder bestuurder)
  • Board composition, Tim Knotnerus (ceo bestuurder)
26-02
Gazette deed Capital & shares · Amendment of the articles
Capital increase · Financial instrument · Kind of shares43 facts ▸
  • General meeting, 15-01-2026 (4 times)
  • Other provision, “EERSTE BESLUIT: Verslagen” (deed in Dutch)
  • Capital increase (5 times)
  • Financial instrument, “IPO Winstbewijs Conversie, conversie” (deed in Dutch)
  • Kind of shares, “IPO Aandelenconversie, conversie” (deed in Dutch)
  • Amendment of the articles (2 times)
  • Capital, “€[]” (deed in Dutch)
  • Financial instrument, “2026 ESOP Warrants” (deed in Dutch)
  • Financial instrument, “waiver preferential rights, in het belang van de Vennootschap” (deed in Dutch)
  • Financial instrument, “company subscription, creatie van een pool van uitstaande 2026 ESOP Warrants voor verdere toekenningen aan Begunstigden” (deed in Dutch)
  • Other provision, “vaststelling van de vergoeding van de bestuurders, (…)” (deed in Dutch)
  • Other provision, 28-01-2026 (3 times)
  • +31 further facts in this act
2025
17-06
Gazette deed Reappointment: Ohad Hammer (klasse a investeerder bestuurder)
Power of attorney7 facts ▸
  • General meeting, 30-05-2025
  • Director reappointment, Ohad Hammer (klasse a investeerder bestuurder)
  • Power of attorney
  • Power of attorney, Ellen Lefever
  • Power of attorney, Silvana Hugue
  • Power of attorney, Joni Oorts
  • Power of attorney, Mats Muys
03-06
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
31-12
Financial Weakest financial yearnet -€11.7m
Net result drops to -€11.7m, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €250mequity €253.7m ▲38.4%
Equity rises from €183.3m to €253.7m.
Show earlier events
19-11
Gazette deed Appointment: BOND Colin Michael (independent director)
Kind of shares · Capital increase · Bank account18 facts ▸
  • General meeting, 04-11-2024
  • Kind of shares, “Bevoorrechte D Aandelen, creatie” (deed in Dutch)
  • Capital increase, €48,359,418.36
  • Bank account, “dossier notaris, ondergetekende notaris” (deed in Dutch)
  • Approval, “ACHTSTE BESLISSING, Kapitaal” (deed in Dutch)
  • Power of attorney (3 times)
  • Power of attorney, Pierre Kemula
  • Power of attorney, Ellen Lefever
  • Amendment of the articles
  • Capital, €223,071,500.16
  • Director appointment, BOND Colin Michael (independent director)
  • Board composition, David Epstein (voorzitter bestuurder en onafhankelijk bestuurder)
  • +6 further facts in this act
18-07
Gazette deed Resignation: John Haurum (voorzitter bestuurder)
Appointment: David Epstein (voorzitter bestuurder) · Financial instrument · Capital increase15 facts ▸
  • General meeting, 08-07-2024
  • Financial instrument, 60, “cancellation” (deed in Dutch)
  • Financial instrument, 60, “uitgiftemodaliteiten en uitoefeningsvoorwaarden zoals vastgesteld in verslagen raad van bestuur vermeld in agendapunten 1 a)en 1 c)” (deed in Dutch)
  • Capital increase (2 times)
  • Power of attorney (6 times)
  • Power of attorney, Ellen Lefever (general counsel) (2 times)
  • Power of attorney, Xavier Van Rillaer (general counsel) (2 times)
  • Financial instrument, 38456, “cancellation” (deed in Dutch)
  • Financial instrument, “2024 Globaal Aandelenoptieplan”, 87780 (deed in Dutch)
  • Director resignation, John Haurum (voorzitter bestuurder)
  • Director discharge, John Haurum
  • Director appointment, David Epstein (voorzitter bestuurder)
  • +3 further facts in this act
17-07
Gazette deed Reappointments: PwC Bedrijfsrevisoren BV, Ohad Hammer and John Haurum
4 facts ▸
  • General meeting, 28-05-2024
  • Auditor reappointment, PwC Bedrijfsrevisoren BV (statutory auditor)
  • Director reappointment, Ohad Hammer (klasse b investeerder bestuurder)
  • Director reappointment, John Haurum
27-06
NBB filing Annual accounts filed
financial year 2023 · abbreviated format
09-04
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 20-03-2024
  • Registered-office move, Posthoflei 1/6, 2600 Berchem (Antwerpen), België
2023
31-12
Financial Equity above €100mequity €183.3m ▲89.2%
Equity rises from €96.9m to €183.3m.
18-10
Gazette deed Resignation: Michael Stewart Lee (klasse b investeerder bestuurder)
Appointments: Xiaoming Fang, Angelika Martha Jahreis and Felice Isabel van Weegen · Kind of shares · Capital increase30 facts ▸
  • General meeting, 10-10-2023
  • Kind of shares, “Bevoorrechte C Aandelen, creatie” (deed in Dutch)
  • Capital increase, €64,299,658.07
  • Bank account, “attest overhandigd aan notaris,bewaard in dossier, artikel 7:195 Wetboek van vennootschappen en verenigingen” (deed in Dutch)
  • Other provision, “boeking uitgifteprijs en uitgiftepremie, ACHTSTE BESLISSING” (deed in Dutch)
  • Amendment of the articles, 5
  • Financial instrument, “nieuw”, 210 (deed in Dutch)
  • Capital increase (2 times)
  • Power of attorney (5 times)
  • Power of attorney, Tolga Hassan (chief financial officer)
  • Power of attorney, Ellen Lefever (chief financial officer)
  • Financial instrument, 16702, “vernietiging” (deed in Dutch)
  • +18 further facts in this act
03-07
NBB filing Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial Liquidity more than triplescurrent ratio 35.92
Current ratio from 9.48 to 35.92; short-term debt falls from €5.6m to €2.3m.
15-07
Gazette deed Capital & shares · Amendment of the articles
Capital increase · Bank account · Share issue13 facts ▸
  • General meeting, 28-06-2022
  • Capital increase, €26,014,423.73
  • Bank account, “bijzondere rekening op naam van de Vennootschap bij BNP Paribas Fortis NV” (deed in Dutch)
  • Share issue, “Anti-dilutie B Warrants”, 50 (deed in Dutch)
  • Share issue, “2022 Employee Stock Optie Warrants”, 41998 (deed in Dutch)
  • Share cancellation, “Globaal Aandelenoptieplan van 05-03-2021, inschrijvingsrechten” (deed in Dutch)
  • Power of attorney, Tolga Hassan (2 times)
  • Power of attorney, Ellen Lefever (2 times)
  • Amendment of the articles
  • Capital, €110,412,423.73
  • Capital increase (2 times)
  • Power of attorney, AgomAb Therapeutics (4 times)
  • +1 further fact in this act
29-06
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
2021
31-12
Financial Equity above €50mequity €67.9m ▲426%
Equity rises from €12.9m to €67.9m.
25-11
Gazette deed Resignation: BDO Bedrijfsrevisoren BV (statutory auditor)
Appointment: PwC Bedrijfsrevisoren BV (statutory auditor) · Permanent representative: Didier Delanoye · Director discharge6 facts ▸
  • General meeting, 29-10-2021
  • Director resignation, BDO Bedrijfsrevisoren BV (statutory auditor)
  • Director discharge, BDO Bedrijfsrevisoren BV
  • Auditor appointment, PwC Bedrijfsrevisoren BV (statutory auditor)
  • Permanent representative, Didier Delanoye
  • Power of attorney, Deloitte Legal - Lawyers
09-11
Gazette deed Capital & shares · Amendment of the articles
Capital increase · Capital · Pre emptive rights waiver6 facts ▸
  • General meeting, 28-10-2021
  • Capital increase, €1,720,000
  • Capital, €84,398,000
  • Amendment of the articles
  • Pre emptive rights waiver, “Afstand van het voorkeurrecht” (deed in Dutch)
  • Power of attorney, AgomAb Therapeutics
16-09
Gazette deed Resignation: Paolo Michieli (director)
2 facts ▸
  • General meeting, 21-05-2021
  • Director resignation, Paolo Michieli (director)
24-05
NBB filing Annual accounts filed
financial year 2020 · abbreviated format
18-03
Gazette deed Resignations: ROZENKRANZ Katja, ZANZINGER Johannes and 2 others
Appointments: KNOTNERUS Tim Jasper (ceo bestuurder) and LEE Michael Stewart (klasse b investeerder bestuurder) · Capital increase · Bank account21 facts ▸
  • General meeting, 05-03-2021
  • Capital increase, €59,780,000
  • Bank account, “BNP Paribas Fortis NV” (deed in Dutch)
  • Share issue, 200, “Anti-dilutie B Warrants” (deed in Dutch)
  • Share issue, 71808, “Employee Stock Optie Warrants” (deed in Dutch)
  • Capital, €82,678,000
  • Amendment of the articles
  • Director resignation, ROZENKRANZ Katja (director)
  • Director resignation, ZANZINGER Johannes (director)
  • Director resignation, COUTET Matthieu (director)
  • Director resignation, POULARD Claire (director)
  • Director appointment, KNOTNERUS Tim Jasper (ceo bestuurder)
  • +9 further facts in this act
2020
31-12
Financial Equity above €10mequity €12.9m ▲95.1%
Equity rises from €6.6m to €12.9m.
25-11
Gazette deed Capital & shares
Capital increase · Premium allocation · Capital8 facts ▸
  • General meeting, 30-10-2020
  • Capital increase, €6,144,381.12
  • Premium allocation, 1190852.88, “Uitgiftepremies” (deed in Dutch)
  • Capital increase, €1,376,361.36
  • Capital, €22,898,000
  • Share issue, “naakte inschrijvingsrechten, op naam”, 11082 (deed in Dutch)
  • Power of attorney
  • Waiver, “Tweede Mijlpalen, artikel 4.4.4 van de inschrijvings- en aandeelhoudersovereenkomst d.d. 04-03-2019, zoals aangepast een eerste maal op 26-06-2019 en een tw…” (deed in Dutch)
31-07
Gazette deed Capital & shares
Capital increase · Reserve release · Amendment of the articles6 facts ▸
  • General meeting, 29-07-2020
  • Capital increase, €957,349.52
  • Reserve release, 185508.48, EUR
  • Amendment of the articles
  • Capital, €15,377,257.52
  • Power of attorney, Deloitte Legal - Lawyers
18-05
NBB filing Annual accounts filed
financial year 2019 · abbreviated format
27-04
Gazette deed Capital & shares
Capital increase · Capital · Share issue9 facts ▸
  • General meeting, 17-04-2020
  • Capital increase, €3,326,795.90
  • Capital increase, €912,781.10
  • Capital, €14,419,908
  • Share issue, “naakte inschrijvingsrechten”, 5543 (deed in Dutch)
  • Amendment of the articles
  • Capital increase
  • Power of attorney, AgomAb Therapeutics
  • Share placement, “door de vennootschap van tijd tot tijd”, 5543 (deed in Dutch)
2019
31-12
Financial Liquidity more than 5 timescurrent ratio 8.66
Current ratio from 1.67 to 8.66.
31-12
Financial Equity above €5mequity €6.6m ▲4,877%
Equity rises from €133,024 to €6.6m.
14-10
Gazette deed Reappointments: MICHIELI Paolo, ROZENKRANZ Katja and 5 others
Capital increase · Capital · Share issue20 facts ▸
  • General meeting, 09-10-2019
  • Capital increase, €3,439,856.98
  • Capital increase, €2,048,897.02
  • Capital, €10,180,331
  • Share issue, “naakte warrants, op naam”, 10 (deed in Dutch)
  • Share issue, “naakte warrants, op naam”, 7237 (deed in Dutch)
  • Share transfer, AgomAb Therapeutics → FCPI CAPITAL INVEST PME 2016
  • Share transfer, AgomAb Therapeutics → BIODISCOVERY 5 FPCI
  • Amendment of the articles
  • Director reappointment, MICHIELI Paolo (director)
  • Director reappointment, ROZENKRANZ Katja (director)
  • Director reappointment, COUTET Matthieu, Philippe, Christian (director)
  • +8 further facts in this act
03-10
Gazette deed Appointment: Tim Knotnerus (day-to-day manager)
Registered-office move3 facts ▸
  • Board meeting, 11-09-2019
  • Director appointment, Tim Knotnerus (day-to-day manager)
  • Registered-office move, Franklin Rooseveltlaan 348, 9000 Gent
11-07
NBB filing Annual accounts filed
financial year 2018 · micro format
01-07
Gazette deed Resignation: WICKE Ilka (director)
Appointment: ZANZINGER Johannes, Friedrich (director) · Capital increase · Capital10 facts ▸
  • General meeting, 27-06-2019
  • Capital increase, €30,297.26
  • Capital increase, €18,279.74
  • Capital, €4,691,577
  • Share issue, “naakte warrants, op naam”, 5 (deed in Dutch)
  • Capital increase
  • Warrant placement, 5, “Anti-Dilutie Warrants” (deed in Dutch)
  • Director resignation, WICKE Ilka (director)
  • Director appointment, ZANZINGER Johannes, Friedrich (director)
  • Mandate compensation, ZANZINGER Johannes, Friedrich
09-04
Gazette deed Capital & shares · Amendment of the articles · Legal-form change · Resignations & appointments
Resignations: MICHIELI Paolo, ROZENKRANZ Katja and 2 others · Appointments: MICHIELI Paolo, ROZENKRANZ Katja and 7 others · Incorporation79 facts ▸
  • General meeting, 14-03-2019
  • Incorporation, 13-04-2017
  • Other provision, “voorzitter, bureau” (deed in Dutch)
  • Capital, €643,000 (2 times)
  • Other provision, “aanwezigheid en quorum”, 40450 (deed in Dutch)
  • Shareholding, 13400, 2.501-15.500,34.101-34.500
  • Shareholding, 7750, 25.001-27.750,29.101-34.100
  • Shareholding, 3250, 16.001-19.000,34.501-34.750
  • Shareholding, 3100, 19.001-22.000,34.751-34.850
  • Shareholding, 2500, 1-2.500
  • Shareholding, 1750, 22.001-23.250,34.851-35.350
  • Shareholding, 1350, 27.751-29.100
  • +67 further facts in this act
2018
12-11
Gazette deed Resignation: TAKKE Christina (manager)
Appointment: COUTET Matthieu Philippe Christian (manager) · Registered-office move · Capital increase10 facts ▸
  • General meeting, 19-10-2018
  • Registered-office move, 9051 Sint-Denijs-Westrem (Gent), Pieter van Reysschootlaan 2/104
  • Capital increase, €200,000
  • Bank account, “BE47 7360 5388 5180” (deed in Dutch)
  • Capital, €643,000
  • Amendment of the articles
  • Director resignation, TAKKE Christina (manager)
  • Director appointment, COUTET Matthieu Philippe Christian (manager)
  • Amendment of the articles, 25
  • Amendment of the articles, 28
13-05
NBB filing Annual accounts filed
financial year 2017 · micro format
14-03
Gazette deed Appointments: TAKKE Christina, ROSENKRANZ Katja and KNOTNERUS Tim Jasper
Share transfer · Capital increase · Bank account13 facts ▸
  • General meeting, 22-02-2018
  • Share transfer, MICHIELI Paolo → KNOTNERUS Tim
  • Capital increase, €110,000
  • Capital increase, €308,000
  • Bank account, “BE84 7340 4448 9259” (deed in Dutch)
  • Capital, €443,000
  • Amendment of the articles
  • Director appointment, TAKKE Christina (manager)
  • Director appointment, ROSENKRANZ Katja (manager)
  • Director appointment, KNOTNERUS Tim Jasper (manager)
  • Mandate compensation, TAKKE Christina
  • Mandate compensation, ROSENKRANZ Katja
  • +1 further fact in this act
2017
30-08
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 23-07-2017
  • Registered-office move, Rijvisschestraat 126- 9052 Zwijnaarde Gent
18-04
Gazette deed Incorporation
Appointment: MICHIELI Paolo (manager) · Founding capital · Bank account6 facts ▸
  • Incorporation, 13-04-2017
  • Founding capital, €25,000
  • Bank account, “BE62 7350 4656 7361 bij KBC Bank NV” (deed in Dutch)
  • Director appointment, MICHIELI Paolo (manager)
  • Mandate compensation, MICHIELI Paolo
  • Capital contribution (7 times)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
29 of 29 deeds read

We would like to set cookies. That happens only with your consent. What we measure